BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 9, 2015
View Archived Issues
Novogen's brain tumor candidate TRXE-009 crosses BBB in animal studies
Read More
Vertex and Parion to develop ENaC inhibitors for cystic fibrosis and pulmonary diseases
Read More
R-Tech Ueno collaborates with Spanish institutions on new drug for cerebral infarction
Read More
BMS starts phase I/IIa trial of ADC in solid tumors
Read More
BeiGene initiates phase I study of BGB-A317 for advanced cancer
Read More
AYX-2 transcription factor decoy shows potential for the treatment of chronic pain
Read More
EC-1456 generally well tolerated in phase I trial
Read More
Regeneron advances two programs: REGN-475 and REGN-2222
Read More
Corcept Therapeutics patents GR modulators
Read More
Jazz Pharmaceuticals starts phase III program for JZP-110 in excessive daytime sleepiness
Read More
Actelion Pharmaceuticals reports TPH1 inhibitors
Read More
CRT and ICR scientists develop Raf kinase B inhibitors
Read More
Phase I data reported for angiogenesis inhibitor TAS-115
Read More
Pivotal Therapeutics starts phase IIa trial of omega-3 fatty acid therapy
Read More
Neurocrine Biosciences suspends two planned trials of NBI-77860
Read More
Lilly reports first human data for Notch signaling inhibitor LY-3039478
Read More
Global Blood Therapeutics reports Hb allosteric modulators
Read More
PlasmaTech obtains license to AAV gene therapy for juvenile Batten disease
Read More
BioMarin files for European approval of drisapersen for DMD
Read More
NCI selects Rexahn's RX-21101 for preclinical characterization program
Read More
Idera and MD Anderson collaborate to conduct trials of intratumoral IMO-2125
Read More
Probuphine noninferior to sublingual buprenorphine in phase III trial in opioid dependence
Read More
PNP Therapeutics gene-directed enzyme prodrug therapy granted FDA orphan designation
Read More
DalCor and Montreal Heart Institute to collaborate on phase III trial of dalcetrapib
Read More
